XWPharma Names Michael M. Morrissey, PhD to Board of Directors
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
REDWOOD CITY, Calif. and WUHAN, China, Dec. 16, 2020 XWPharma Ltd. today announced that Michael M. Morrissey, Ph.D. has been appointed to the company’s Board of Directors. Dr. Morrissey brings extensive experience as a scientist, leader of highly productive Research and Development organizations, and chief executive officer of a fully-integrated, widely respected biopharma company.
“We are very excited to welcome Mike to our Board,” said Leonard Blum, XWPharma President and CEO. “As a seasoned R&D and company leader, his perspective will be invaluable as we prioritize the multiple high potential opportunities our research unit has identified and navigate the evolving landscape of creating first of their kind therapeutics for patients suffering from CNS disorders with compelling unmet needs.”
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
XWPharmaDecember 16, 2020 GMT
REDWOOD CITY, Calif. and WUHAN, China, Dec. 16, 2020 (GLOBE NEWSWIRE) XWPharma Ltd. today announced that Michael M. Morrissey, Ph.D. has been appointed to the company’s Board of Directors. Dr. Morrissey brings extensive experience as a scientist, leader of highly productive Research and Development organizations, and chief executive officer of a fully-integrated, widely respected biopharma company.
“We are very excited to welcome Mike to our Board,” said Leonard Blum, XWPharma President and CEO. “As a seasoned R&D and company leader, his perspective will be invaluable as we prioritize the multiple high potential opportunities our research unit has identified and navigate the evolving landscape of creating first of their kind therapeutics for patients suffering from CNS disorders